Repair of osteochondral defects with adipose stem cells and a dual growth factor-releasing scaffold in rabbits

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 2, 2010, Pages 552-560

  Im, Gun Il ^a   Lee, Jin Ho ^b  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Hannam University   (South Korea)

Author keywords

Cartilage; Growth factor immobilized scaffold; Polycaprolactone; Stem cells; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEINS; CARTILAGE DEFECTS; CARTILAGE GROWTH; DISTAL FEMURS; FOREIGN BODY GIANT CELLS; FOREIGN BODY REACTIONS; GROUP III; GROWTH FACTOR; GROWTH FACTOR-IMMOBILIZED SCAFFOLD; IN-VIVO; OSTEOCHONDRAL DEFECTS; STEM CELL;

BIOACTIVITY; BLOOD VESSELS; CARTILAGE; DEFECTS; LIGAMENTS; PEPTIDES; POLYCAPROLACTONE; STEM CELLS; TISSUE ENGINEERING;

SCAFFOLDS;

OSTEOGENIC PROTEIN 1; POLYCAPROLACTONE; SCAFFOLD PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE REMODELING; CARTILAGE INJURY; CELL INFILTRATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMUR; FRACTURE HEALING; GIANT CELL; HISTOLOGY; IMPLANTATION; IN VIVO STUDY; NONHUMAN; PATELLA; PROTEIN IMMOBILIZATION; RABBIT; SCORING SYSTEM; STEM CELL;

ADIPOCYTES; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 7; CARTILAGE; CELL DIFFERENTIATION; CELL SEPARATION; CHONDROCYTES; FIBRINOLYTIC AGENTS; HEPARIN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOCYTES; PHENAZINES; POLOXAMER; POLYESTERS; RABBITS; REGENERATION; STEM CELLS; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 74749098555     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31552     Document Type: Article

References (33)

1. Caplan AI, Goldberg VM. Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop 1999;367:S12-S16.
2. Buckwalter JA, Mankin HJ. Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 1988;47:487-504.
3. Childers JC Jr, Ellwood SC. Partial chondrectomy and subchondral bone drilling for chondromalacia. Clin Orthop Relat Res 1979;144:114-120.
4. Breinan HA, Martin SD, Hsu HP, Spector M. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J Orthop Res 2000;18:781-789.
5. Beiser IH, Kanat IO. Subchondral bone drilling: A treatment for cartilage defects. J Foot Surg 1990;29:595-601.
6. Minas T, Nehrer S. Current concepts in the treatment of articular cartilage defects. Orthopedics 1997;20:525-538.
7. O' Driscoll SW. The healing and regeneration of articular cartilage. J Bone Joint Surg Am 1998;80:1795-1812.
8. Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003;22:81-91.
9. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS. A three-dimensional nano.brous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005;26:599-609.
10. Takahashi Y, Yamamoto M, Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 2005;26:4856-4865.
11. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
12. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228.
13. Nathan S, Das De S, Thambyah A, Fen C, Goh J, Lee EH. Cell-based therapy in the repair of osteochondral defects: A novel use for adipose tissue. Tissue Eng 2003;9:733-744.
14. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison. J Orthop Res 2005;23:1383-1389.
15. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr Cartil 2005;13:845-853.
16. 2 and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 2008;15:1543-1551.
17. Kim HJ, Im GI. Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: Greater doses of growth factor are necessary. J Orthop Res 2009;27:612-619.
18. Woodward SC, Brewer PS, Moatamed F, Schindler A, Pitt CG. The intracellular degradation of poly(ε-caprolactone). J Biomed Mater Res 1985;19:437-444.
19. Ng KW, Hutmacher DW, Schantz JT, Ng CS, Too HP, Lim TC, Phan TT, Teoh SH. Evaluation of ultra-thin poly(ε-caprolactone) films for tissue-engineered skin. Tissue Eng 2001;7:441-455.
20. Fecek C, Yao D, Kaçorri A, Vasquez A, Iqbal S, Sheikh H, Svinarich DM, Perez-Cruet M, Chaudhry GR. Chondrogenic derivatives of embryonic stem cells seeded into 3D polycaprolactone scaffolds generated cartilage tissue in vivo. Tissue Eng Part A 2008;14:1403-1413.
21. Wise JK, Yarin AL, Megaridis CM, Cho M. Chondrogenic differentiation of human mesenchymal stem cells on oriented nanofibrous scaffolds: Engineering the superficial zone of articular cartilage. Tissue Eng Part A 2009;15:913-921.
22. Lin CH, Su JM, Hsu SH. Evaluation of type II collagen scaffolds reinforced by poly(ε-caprolactone) as tissue-engineered trachea. Tissue Eng Part C: Methods 2008;14:69-77.
23. Kim HJ, Lee JH, Im GI. Chondrogenesis using mesenchymal stem cells and PCL scaffolds. J Biomed Mater Res A. Forthcoming; Epub ahead of print.
24. Oh SH, Park IK, Kim JM, Lee JH. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 2007;28:1664-1671.
25. Wu ZL, Zhang L, Yabe T, Kuberan B, Beeler DL, Love A, Rosenberg RD. The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 2003;278:17121-17129.
26. Yoon JJ, Chung HJ, Lee HJ, Park TG. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 2006;79:934-942.
27. Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lacticco-glycolic acid) scaffold. Biomaterials 2007;28:2763-2771.
28. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-βs with heparin/heparin sulfate is isoform-specifc. J Biol Chem 1997;272:18000-18006.
29. Oh SH, Kang SG, Kim ES, Cho SH, Lee JH. Fabrication and characterization of hydrophilic poly(lactic-co-glycolic acid)/poly(vinyl alcohol) blend cell scaffolds by melt-molding particulate-leaching method. Biomaterials 2003;24:4011-4021.
30. Lim SM, Jang SW, Oh SH, Yuk SH, Im GI, Lee JH. Dual growth factor-releasing PCL scaffolds for chondrogenesis of adipose tissue-derived mesenchymal stem cells. Advanced Engineering Materials. Forthcoming.
31. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 2000;374:212-234.
32. Mainil-Varlet P, Aigner T, Brittberg M, Bullough P, Hollander A, Hunziker E, Kandel R, Nehrer S, Pritzker K, Roberts S, Stauffer E; International Cartilage Repair Society. Histological assessment of cartilage repair: A report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am 2003;85 (Suppl 2):45-53.
33. Ahn JH, Lee TH, Oh JS, Kim SY, Kim HJ, Park IK, Choi BS, Im GI. A novel hyaluronate-atelocollagen/β-TCP-hydroxyapatitebiphasic scaffold for the repair of osteochondral defects in rabbits. Tissue Eng Part A 2009;15:2595-2604.